You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -71,250.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -0.9 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 1,976.7 | n/a |
| Price / Book value | 3.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | n/a | -1.57 | -0.96p | -8.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -1.84 | -0.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | n/a | -1.19 | -0.55p | -3.4 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 0.00 | -1.42 | -0.52p | -1.6 | 0.0 | n/a | n/a | 0.0% |
| N4 Pharma files for new UK patent Sharecast News | 04 Dec |
|---|---|
| N4 Pharma reports positive progress with SRI collaboration Sharecast News | 20 Aug |
| N4 Pharma shares tank after £0.6m fundraise Sharecast News | 07 Jun |
| Change of Registered Address | 15-May-25 15:13 |
|---|---|
| N4 101 In Vivo Study Results | 12-May-25 07:01 |
| Holding(s) in Company | 09-May-25 08:24 |
| Holding(s) in Company | 29-Apr-25 23:07 |
| Holding(s) in Company | 29-Apr-25 23:06 |